Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1421
-
Total 13F shares, excl. options
-
1.26B
-
Shares change
-
-47.6M
-
Total reported value, excl. options
-
$119B
-
Value change
-
-$4.58B
-
Put/Call ratio
-
1.42
-
Number of buys
-
712
-
Number of sells
-
-601
-
Price
-
$94.26
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2014
1,593 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2014.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,421 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.26B shares
.
Largest 10 shareholders include Capital Research Global Investors (97.9M shares), FMR LLC (94.4M shares), VANGUARD GROUP INC (81.6M shares), State Street Corp (64.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (51.6M shares), BlackRock Institutional Trust Company, N.A. (40.6M shares), Bank of New York Mellon Corp (27.1M shares), BlackRock Fund Advisors (23.4M shares), JPMORGAN CHASE & CO (22.2M shares), and Invesco Ltd. (21.5M shares).
This table shows the top 1421 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.